Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Jamieson Wellness Inc T.JWEL

Alternate Symbol(s):  JWLLF

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. It offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. The company also provides plant-based products under the Iron Vegan brand; natural health products f...


TSX:JWEL - Post by User

Post by retiredcfon Mar 02, 2026 8:29am
38 Views
Post# 36916802

TD Raises Target

TD Raises Target

Consistent, Defensive Growth Not Reflected In

The Multiple: Top Small Cap Pick

THE TD COWEN INSIGHT
 

JWEL shares are up 10% YTD, although we still feel that the shares are undervalued given the

company's earnings consistency. This is driven by benefits stemming from the resiliency of

consumer health spending. JWEL recorded another solid year, and we expect this success

to continue in 2026 across all of its segments. We are raising our TP to $48 (from $46). JWEL remains our top small cap pick.

 

Impact: SLIGHTLY POSITIVE
 

This was another quality quarterly result, driven by healthy consumption growth across geographies, channels, and brands:

Canada: Strong MSD% y/y dollar and POS growth driven by quality-focused marketing campaigns and innovation.

youtheory: 20% y/y revenue growth (ahead of our forecast) due to the continued success of both e-commerce and traditional channels.

China: A 44% sales increase (19% higher than our estimate) due to (even greater) brand awareness and growing share in the club/retail channels, among other factors.

International: 39% increase owing to strong consumption and organic growth in key markets (inc. the Middle East).

We adjusted our model for Q4 results and management's 2026 guide (see Fig. 2 and 3 for details). We'd highlight that flat EBITDA margin expectations for the Jamieson Brands

segment are owing to continued category strength across it geographic markets, albeit skewed towards China as it continues to experience "supercharged" growth (i.e. lower margin business). All other changes reflect fine-tuning.

We are raising our TP to $48 (up from $46) after rolling out valuation another quarter.
 

Looking out further, we are confident that given its platform and innovation pipeline, JWEL

is well-positioned to move towards a $1bln top line on the back of consistent double-digit

revenue and EBITDA growth. Despite all of this, including another solid quarter and annual

performance, shares are trading at just 10.8x forward consensus EBITDA. This is still below

JWEL's 2-year historical average of 11.2x and well below the ~15.8x at which Blackmores was

acquired just a few years ago.



<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities